BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1078 related articles for article (PubMed ID: 10823264)

  • 1. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment with enoxaparin adapted to the fertility programs in women with recurrent abortion and thrombophilia].
    Sarto A; Rocha M; Geller M; Capmany C; Martínez M; Quintans C; Donaldson M; Pasqualini RS
    Medicina (B Aires); 2001; 61(4):406-12. PubMed ID: 11563168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss.
    Sarig G; Blumenfeld Z; Leiba R; Lanir N; Brenner B
    Thromb Haemost; 2005 Nov; 94(5):980-5. PubMed ID: 16363240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited thrombophilia: treatment during pregnancy.
    De Carolis S; Ferrazzani S; De Stefano V; Garofalo S; Fatigante G; Rossi E; Leone G; Caruso A
    Fetal Diagn Ther; 2006; 21(3):281-6. PubMed ID: 16601339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia.
    Mitić G; Novakov Mikić A; Povazan L; Mitreski A; Kopitović V; Vejnović T
    Med Pregl; 2011; 64(9-10):471-5. PubMed ID: 22097113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants.
    Grandone E; De Stefano V; Rossi E; Cappucci F; Colaizzo D; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):226-30. PubMed ID: 18388503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.
    Ramidi G; Khan N; Glueck CJ; Wang P; Goldenberg N
    Transl Res; 2009 Jan; 153(1):33-43. PubMed ID: 19100956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of pregnancies in women with thrombophilic disorders.
    Sucak A; Acar K; Celen S; Danisman N; Sucak GT
    J Obstet Gynaecol; 2010; 30(8):847-51. PubMed ID: 21126128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
    Visser J; Ulander VM; Helmerhorst FM; Lampinen K; Morin-Papunen L; Bloemenkamp KW; Kaaja RJ
    Thromb Haemost; 2011 Feb; 105(2):295-301. PubMed ID: 21103659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial.
    Qublan H; Amarin Z; Dabbas M; Farraj AE; Beni-Merei Z; Al-Akash H; Bdoor AN; Nawasreh M; Malkawi S; Diab F; Al-Ahmad N; Balawneh M; Abu-Salim A
    Hum Fertil (Camb); 2008 Dec; 11(4):246-53. PubMed ID: 19085261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance to activated protein C and pregnancy: thromboprophylaxis with low molecular weight heparin].
    Barjot P; Beucher G; Le Querrec A; Derlon-Borel A; Herlicoviez M
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):544-9. PubMed ID: 10598348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
    Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
    Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombophilic dimension of recurrent fetal loss in Indian patients.
    Vora S; Shetty S; Ghosh K
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):581-4. PubMed ID: 18685442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Ramadan DI; Fouda IM
    J Obstet Gynaecol; 2010; 30(8):842-6. PubMed ID: 21126127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
    Pauzner R; Dulitzki M; Langevitz P; Livneh A; Kenett R; Many A
    Thromb Haemost; 2001 Dec; 86(6):1379-84. PubMed ID: 11776303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
    de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin.
    Glueck CJ; Wang P; Goldenberg N; Sieve L
    Clin Appl Thromb Hemost; 2004 Oct; 10(4):323-34. PubMed ID: 15497018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.